Denise J. Lo

Denise J. Lo

Auto-generated profile, based on publicly available information

Denise J. Lo

Department of Surgery, Emory University School of Medicine, Atlanta, GA, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2019 in Journal of Medical Internet Research
Verified
Journal Article
Open access
JWJoel Wedd
Joel Wedd
MBMohua Basu
Mohua Basu
LCLaura M Curtis
Laura M Curtis
KSKayla Smith
Kayla Smith
DLDenise J Lo
Denise J Lo
RPRachel E Patzer
Rachel E Patzer
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Kidney and liver transplant recipients must manage a complex care regimen after kidney transplant. Although the use of web-based patient portals is known to improve patient-provider communication and health outcomes in chronic disease populations by helping patients manage post-transplant care, disparities in access to and use of portals have been reported. Little is known about portal usage and disparities among kidney and liver transplant recipients. Objective: The aim of this study was to examine patient demographic, clinical, and socioeconomic characteristics associated with portal usage among kidney and liver transplant recipients. Methods: The study included all adult kidney and liver transplant recipients (n=710) at a large academic transplant center in the Southeastern United States between March 2014 and November 2016. Electronic health record data was linked with Cerner portal usage data. Patient portal use was defined as any portal activity (vs. no activity) recorded in the Cerner web-based portal, including viewing of health records, lab results, medication lists, and the use of secure messaging. Multivariable log-binomial regression was used to determine the patient demographic, clinical, and socioeconomic characteristics associated with portal usage, stratified by organ. Results: Among 710 transplant recipients (n=455 kidney, n=255 liver), 55% of kidney recipients and 48% of liver recipients used the patient portal. Black patients were less likely to use the portal vs. white patients among both kidney (57% black vs. 74% white) and liver (28% black vs. 55% white) transplant recipients. In adjusted multivariable analyses, kidney transplant recipients were more likely to use the portal if they had higher education; among liver recipients, patients who were white vs. black race, and had higher education were more likely to use the portal. Conclusions: Patient portals have the potential to benefit transplant recipients as a tool for health management, but racial and socioeconomic disparities should be considered prior to widespread implementation. Transplant centers should include portal training and support to all patients to encourage use given its potential to improve outcomes.

15 September 2020 in American Journal of Transplantation
Verified
Journal Article
Open access
SPSudeshna Paul
Sudeshna Paul
TMTaylor Melanson
Taylor Melanson
SMSumit Mohan
Sumit Mohan
KRKatherine Ross-Driscoll
Katherine Ross-Driscoll
LMLaura McPherson
Laura McPherson
RPRachel E. Patzer
Rachel E. Patzer
Kidney transplant program performance in the United States is commonly measured by posttransplant outcomes. Inclusion of pretransplant measures could provide a more comprehensive assessment of transplant program performance and necessary information for patient decision-making. In this study, we propose a new metric, the waitlisting rate, defined as the ratio of patients who are waitlisted in a center relative to the person-years referred for evaluation to a program. Furthermore, we standardize the waitlisting rate relative to the state average in Georgia, North Carolina, and South Carolina. The new metric was used as a proof-of-concept to assess transplant-program access compared to the existing transplant rate metric. The study cohorts were defined by linking 2017 United States Renal Data System (USRDS) data with transplant-program referral data from the Southeastern United States between January 1, 2012 and December 31, 2016. Waitlisting rate varied across the 9 Southeastern transplant programs, ranging from 10 to 22 events per 100 patient-years, whereas the program-specific waitlisting rate ratio ranged between 0.76 and 1.33. Program-specific waitlisting rate ratio was uncorrelated with the transplant rate ratio (r = −.15, 95% CI, −0.83 to 0.57). Findings warrant collection of national data on early transplant steps, such as referral, for a more comprehensive assessment of transplant program performance and pretransplant access.

17 May 2025 in American Journal of Transplantation
Verified
Journal Article
Open access
DLDenise J. Lo
Denise J. Lo
JMJoseph F. Magliocca
Joseph F. Magliocca
KRKatherine Ross-Driscoll
Katherine Ross-Driscoll
Pediatric liver transplant (LT) waitlist mortality remains unacceptably high. In 2020, the Organ Procurement and Transplantation Network (OPTN) implemented acuity circle (AC)-based liver distribution and national pediatric prioritization for pediatric donor livers. Using OPTN data, waitlist outcomes for pediatric LT candidates listed between February 4, 2016 and February 3, 2024, were studied by age group and era relative to AC implementation. There were 5,605 waitlist registrations and 3,778 liver transplants. At 1 year, cumulative incidence of transplant was 77.8% pre-AC vs 79.9% post-AC; cumulative incidence of mortality was 5.4% pre-AC vs 5.9% post-AC. Median allocation Model for End-Stage Liver Disease/Pediatric Model for End-Stage Liver Disease score at LT significantly decreased across all age groups post-AC (p<0.001). Candidates age 12-17 years experienced higher cumulative incidence of transplant (65.6% pre-AC vs 79.5% post-AC at 1 year), decreased median time to transplant (66 days pre-AC vs 37 days post-AC, p<0.001), and increased proportion of pediatric donor livers (37.9% pre-AC vs 66.2% post-AC, p<0.001). AC group was associated with increased likelihood of transplant for those age 12-17 years and increased likelihood of waitlist mortality for those age 1-5 years. LT candidates age 12-17 years derived the most benefit from AC-based liver distribution.

15 July 2014 in Transplantation
Verified
Journal Article
Open access
MSM. Song
M. Song
DLD. Lo
D. Lo
RWR. Wang
R. Wang
KRK. Reimann
K. Reimann
TST. Springer
T. Springer
AKA. Kirk
A. Kirk

7 August 2018 in JMIR Preprints
Verified
Preprint
Open access
JWJoel Wedd
Joel Wedd
MBMohua Basu
Mohua Basu
LCLaura M Curtis
Laura M Curtis
KSKayla Smith
Kayla Smith
DLDenise J Lo
Denise J Lo
RPRachel E Patzer
Rachel E Patzer
BACKGROUND Kidney and liver transplant recipients must manage a complex care regimen after kidney transplant. Although the use of Web-based patient portals is known to improve patient-provider communication and health outcomes in chronic disease populations by helping patients manage posttransplant care, disparities in access to and use of portals have been reported. Little is known about portal usage and disparities among kidney and liver transplant recipients. OBJECTIVE The aim of this study was to examine patient racial/ethnic, socioeconomic, and clinical characteristics associated with portal usage among kidney and liver transplant recipients. METHODS The study included all adult kidney and liver transplant recipients (n=710) at a large academic transplant center in the Southeastern United States between March 2014 and November 2016. Electronic medical record data were linked with Cerner portal usage data. Patient portal use was defined as any portal activity (vs no activity) recorded in the Cerner Web-based portal, including viewing of health records, lab results, medication lists, and the use of secure messaging. Multivariable log-binomial regression was used to determine the patient demographic, clinical, and socioeconomic characteristics associated with portal usage, stratified by organ. RESULTS Among 710 transplant recipients (n=455 kidney, n=255 liver), 55.4% (252/455) of kidney recipients and 48.2% (123/255) of liver recipients used the patient portal. Black patients were less likely to use the portal versus white patients among both kidney (57% black vs 74% white) and liver (28% black vs 55% white) transplant recipients. In adjusted multivariable analyses, kidney transplant recipients were more likely to use the portal if they had higher education; among liver recipients, patients who were white versus black and had higher education were more likely to use the portal. CONCLUSIONS Despite studies showing that patient portals have the potential to benefit transplant recipients as a tool for health management, racial and socioeconomic disparities should be considered before widespread implementation. Transplant centers should include portal training and support to all patients to encourage use, given its potential to improve outcomes.

12 July 2022 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
DLDenise J Lo
Denise J Lo
An abstract is unavailable. This article is available as a PDF only.